Skip to content
Screener

CareDx CDNA Q1 2026 earnings

Reported April 28, 2026 · After market close

Revenue$117.7MBeat by $15.7M
EPS$0.34Beat by $0.23
Revenue estimate$102.0M
EPS estimate$0.11

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$121.9M
EPS estimate$0.24

Financials

Q1 2026

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$889.12M-9.6%
Enterprise value$835.14M-9.7%
P/S2.2×-0.7×

Profitability

See full
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Segments

By product

See full
Testing services revenue$91.4M+47.6%
Patient and digital solutions revenue$16.0M+33.5%

By segment

See full
Reportable Segment$117.7M+39.0%

FAQ

When did CareDx report Q1 2026 earnings?
CareDx (CDNA) reported Q1 2026 earnings on April 28, 2026 after market close.
What were CareDx's Q1 2026 revenue and EPS?
CareDx reported revenue of $117.7M and eps of $0.34 for Q1 2026.
Did CareDx beat estimates in Q1 2026?
Revenue beat the consensus estimate of $102.0M by $15.7M. EPS beat the consensus estimate of $0.11 by $0.23.
How did CareDx's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 39.0% from $84.7M a year earlier and eps grew 277.8% from $0.09.
Where can I find CareDx's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-050317) and the 10-Q periodic report (0001217234-26-000033) directly on SEC EDGAR. The filing index links above go to sec.gov.